Finding the best laws to reduce opioid-related harm in the U.S.
Large Data Spatiotemporal Modeling of Optimal Combinations of Interventions to Reduce Opioid Harm in the United States
['FUNDING_R01'] · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · NIH-10864986
This study is looking at the best ways to combine laws about drug use and safety tools to help reduce opioid overdoses and injuries in the U.S., so we can find out what works best for communities.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NEW YORK UNIVERSITY SCHOOL OF MEDICINE (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-10864986 on ClinicalTrials.gov |
What this research studies
This research aims to identify the most effective combinations of harm reduction and drug paraphernalia laws to decrease opioid overdoses and related injuries in the United States. The project involves reviewing existing laws in large municipalities, conducting surveys on law enforcement implementation, and creating a comprehensive dataset that merges various data sources. By analyzing this data, the research will determine which policies have been most successful in reducing opioid-related harm and how local characteristics influence these outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals living in areas heavily impacted by opioid use and those interested in harm reduction strategies.
Not a fit: Patients who do not reside in urban areas or those not affected by opioid use may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective laws and policies that significantly reduce opioid overdoses and improve public health.
How similar studies have performed: Previous research has shown that targeted policy interventions can effectively reduce opioid-related harm, suggesting that this approach has the potential for success.
Where this research is happening
NEW YORK, UNITED STATES
- NEW YORK UNIVERSITY SCHOOL OF MEDICINE — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CERDA, MAGDALENA — NEW YORK UNIVERSITY SCHOOL OF MEDICINE
- Study coordinator: CERDA, MAGDALENA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome, Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome Virus